Press Releases

Date	Title
3/27/25	Pulse Biosciences Reports Business Updates and Fourth Quarter & Full Year 2024 Financial Results
3/26/25	Pulse Biosciences To Present at the 24th Annual Needham Virtual Health Care Conference
3/7/25	Pulse Biosciences Schedules Fourth Quarter & Full Year 2024 Financial Results Conference Call for March 27, 2025
3/4/25	Pulse Biosciences Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
2/20/25	Pulse Biosciences To Present at the TD Cowen 45th Annual Health Care Conference
2/4/25	Pulse Biosciences, Inc. Appoints Jon Skinner as Chief Financial Officer
1/30/25	Pulse Biosciences’ Nanosecond PFA Technology to Be Featured in Presentations at North American Society for Interventional Thyroidology Annual Meeting
1/21/25	Pulse Biosciences Announces Late-Breaking Data from its Nanosecond PFA 360° Cardiac Catheter System First-In-Human Feasibility Study Presented at the AF Symposium
1/13/25	Pulse Biosciences’ Nanosecond PFA Technology to be Featured in Multiple Presentations at the AF Symposium
1/10/25	Pulse Biosciences, Inc. Appoints Paul LaViolette as Chief Executive Officer

Keyword Search